Join
Live feed
·
INSIDERFilingvia Quantisnow
Celularity Inc. logo

Sorrento Therapeutics, Inc. sold 15,371,697 shares, decreasing direct ownership by 75% to 5,050,427 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CELU· Celularity Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CELU (Celularity Inc.) and more on Quantisnow.